Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | Director | February 15, 2026 | February 18, 2026 |
| CASTLE BIOSCIENCES INCCSTL · Entity 359 | Director | July 16, 2020 | July 28, 2020 |
| VERACYTE, INC.VCYT · Entity 2018 | Director | June 02, 2023 | June 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date February 15, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,847 |
Reported balance
After 2026-02-15 transaction · row 1
1 source rowRow 1 · 2026-02-15 · Grant · Acquired 4,520 · Balance 17,847 F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
CASTLE BIOSCIENCES INC
Report date July 16, 2020 · Filed July 28, 2020 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy trust | 21,723 |
Last balance in matching sequence
After 2020-07-16 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2020-07-16 · Sale · Disposed 1,228 · Balance 23,495 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F2: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Row 2 · 2020-07-16 · Sale · Disposed 1,763 · Balance 21,732 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F4: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Row 3 · 2020-07-16 · Sale · Disposed 9 · Balance 21,723 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020.
F2: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust.
F4: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
VERACYTE, INC.
Report date June 02, 2023 · Filed June 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,377 |
Reported balance
After 2023-06-02 transaction · row 1
1 source rowRow 1 · 2023-06-02 · Tax withholding · Disposed 1,304 · Balance 41,377 F1: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person. |
| Common StockSEC Table I · non-derivative | IndirectThe Bonnie H. Anderson Living Trust | 134,800 |
Reported balance
Holding disclosure · report date 2023-06-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 134,800 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2018 Filed Jun 27, 2018 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 5,086 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-18-000054 · wf-form4_153013433764259.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 5,086 shares Expires 2020-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F4 · derivative.exercise_date: The option became exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 6,000 | $9.26 | $55,551.60 |
DisclosureSEC source: 0001384101-18-000054 · wf-form4_153013433764259.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,541 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $9.11 to $9.41. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 914 | $2.68 | $2,449.52 |
DisclosureSEC source: 0001384101-18-000054 · wf-form4_153013433764259.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 5,086 | $2.36 | $12,002.96 |
DisclosureSEC source: 0001384101-18-000054 · wf-form4_153013433764259.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-18-000050 · wf-form4_152900698696730.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,086 Underlying: Common Stock · 12,000 shares Expires 2020-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F4 · derivative.exercise_date: The option became exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 12,000 | $8.00 | $96,049.20 |
DisclosureSEC source: 0001384101-18-000050 · wf-form4_152900698696730.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,541 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $8.00 to $8.07. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 12,000 | $2.36 | $28,320.00 |
DisclosureSEC source: 0001384101-18-000050 · wf-form4_152900698696730.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 00:56 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001384101-18-000014 · wf-form4_152029778513671.xml · derivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2028-03-02 F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous employment thereafter. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 00:56 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-18-000014 · wf-form4_152029778513671.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,541 F1 · shares: Restricted stock units (RSUs) awarded on March 2, 2018 vest 25% on March 2, 2019, and the remaining vest at a rate of 3/48 on each quarterly anniversary thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:57 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 6,388 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-17-000070 · wf-form4_151026822710645.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,526 Underlying: Common Stock · 6,388 shares Expires 2020-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became fully vested and immediately exercisable on September 28, 2014. The option award vested as to 1/4 of the total number of shares subject to the option after one year of continuous service commencing September 28, 2010, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the option for each month of continuous service thereafter. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:57 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 6,153 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001384101-17-000070 · wf-form4_151026822710645.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,153 shares Expires 2020-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became fully vested and immediately exercisable on February 3, 2012. The option award vested at a rate of 1/24th of the total number of shares subject to the award per month of continuous service commencing February 3, 2010. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:57 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 6,388 | $2.36 | $15,075.68 |
DisclosureSEC source: 0001384101-17-000070 · wf-form4_151026822710645.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:57 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 6,153 | $0.80 | $4,922.40 |
DisclosureSEC source: 0001384101-17-000070 · wf-form4_151026822710645.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2017 Filed Oct 20, 2017 20:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $2.68 Strike: $2.68 | $26,800.00 |
DisclosureSEC source: 0001384101-17-000064 · wf-form4_150853236240095.xml · derivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,219 Underlying: Common Stock · 10,000 shares Expires 2022-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| October 20, 2017 Filed Oct 20, 2017 20:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 10,000 | $9.60 | $96,000.00 |
DisclosureSEC source: 0001384101-17-000064 · wf-form4_150853236240095.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · security: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F3 · price: Actual sales price. Read SEC document |
| October 20, 2017 Filed Oct 20, 2017 20:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 10,000 | $2.68 | $26,800.00 |
DisclosureSEC source: 0001384101-17-000064 · wf-form4_150853236240095.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 20:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 6,000 | $2.36 Strike: $2.36 | $14,160.00 |
DisclosureSEC source: 0001384101-17-000064 · wf-form4_150853236240095.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,086 Underlying: Common Stock · 6,000 shares Expires 2020-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 20:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 6,000 | $9.09 | $54,556.20 |
DisclosureSEC source: 0001384101-17-000064 · wf-form4_150853236240095.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · security: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $8.82 to $9.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 20:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 6,000 | $2.36 | $14,160.00 |
DisclosureSEC source: 0001384101-17-000064 · wf-form4_150853236240095.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 20:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 6,000 | $2.36 Strike: $2.36 | $14,160.00 |
DisclosureSEC source: 0001384101-17-000058 · wf-form4_150654562027091.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,086 Underlying: Common Stock · 6,000 shares Expires 2020-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option became exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 20:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 6,000 | $8.44 | $50,623.80 |
DisclosureSEC source: 0001384101-17-000058 · wf-form4_150654562027091.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · security: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $8.27 to $8.55. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 20:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 6,000 | $2.36 | $14,160.00 |
DisclosureSEC source: 0001384101-17-000058 · wf-form4_150654562027091.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:28 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001384101-17-000022 · wf-form4_149030091110984.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,153 Underlying: Common Stock · 5,000 shares Expires 2020-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests monthly over a two year period. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:28 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 5,000 | $9.09 | $45,435.00 |
DisclosureSEC source: 0001384101-17-000022 · wf-form4_149030091110984.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · security: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 15, 2016. F2 · price: Represents weighted average sale price. Sale prices for the transactions range from $9.00 to $9.18. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:28 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 5,000 | $0.80 | $4,000.00 |
DisclosureSEC source: 0001384101-17-000022 · wf-form4_149030091110984.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 22:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 310,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001384101-17-000017 · wf-form4_148883804541459.xml · derivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 Underlying: Common Stock · 310,000 shares Expires 2027-03-03 F1 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.